Sabra Healthcare SBRA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $812.84M+12.9% | $774.63M+10.2% | $745.08M+8.9% | $733.04M+9.8% | $720.03M+10.3% | ||
| $55.84M+9.7% | $53.71M+7.3% | $50.83M-5.4% | $50.68M-2.7% | $50.91M+4.2% | ||
| —— | —— | —— | —— | —— | ||
| $113.8M-0.1% | $112.49M-2.4% | $111.63M-12.3% | $112.2M-10.9% | $113.96M-8.8% | ||
| $152.35M+7.8% | $153.42M+19.8% | $174.6M+75.7% | $182.19M+225% | $141.31M+162% | ||
| $1.95M+102% | $1.84M+82.8% | $1.73M+54.4% | $1.03M-44.2% | $965K-44.1% | ||
| $156.19M+11.0% | $155.61M+22.8% | $175.08M+80.2% | $182.33M+249% | $140.76M+184% | ||
| 19.2%-0.3pp | 20.1%+2.1pp | 23.5%+9.3pp | 24.9%+17.0pp | 19.5%+12.0pp | ||
| $0.63+5.0% | $0.64+18.5% | $0.73+78.0% | $0.77+267% | $0.60+200% | ||
| $462.78M+8.8% | $452.9M+9.7% | $464.14M+17.0% | $466.49M+32.3% | $425.48M+20.9% | ||
| 56.9%-2.2pp | 58.5%-0.3pp | 62.3%+4.3pp | 63.6%+10.8pp | 59.1%+5.2pp | ||
| $266.15M+4.3% | $265.91M+9.3% | $286.24M+26.3% | $294.38M+61.8% | $255.28M+42.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Sabra Healthcare's revenue?
- Sabra Healthcare (SBRA) generated $812.8M in revenue over the trailing twelve months, up 12.9% year over year.
- Is Sabra Healthcare profitable?
- Sabra Healthcare reported $156.2M in net income over the trailing twelve months, a 19.2% net margin.
- What is Sabra Healthcare's earnings per share?
- Sabra Healthcare's diluted EPS over the trailing twelve months is $0.63.
- Where does Sabra Healthcare's income statement data come from?
- Every line is extracted from Sabra Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
